Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAGE Sage Therapeutics

盘前交易 07-22 05:02:09 EDT

12.29

+0.12

+0.99%

最高12.55	最低12.00	成交量81.53万
今开12.10	昨收12.17	日振幅4.52%
总市值7.40亿	流通市值5.84亿	总股本6,018万
成交额1,004万	换手率1.72%	流通股本4,752万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAGE","market":"US","secType":"STK","nameCN":"Sage Therapeutics","latestPrice":12.29,"timestamp":1721419200000,"preClose":12.17,"halted":0,"volume":815274,"delay":0,"floatShares":47517185,"shares":60182031,"eps":-8.392453,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.12,"latestTime":"07-22 05:02:09 EDT","open":12.1,"high":12.55,"low":12,"amount":10038738.617694,"amplitude":0.045193,"askPrice":12.4,"askSize":3,"bidPrice":12.2,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-8.392453,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1405656000000,"adjPreClose":12.29,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":12.39,"preClose":12.29,"latestTime":"17:07 EDT","volume":17518,"amount":215353.99,"timestamp":1721423262424},"volumeRatio":1.042367790757233,"impliedVol":1.2476,"impliedVolPercentile":0.952},"requestUrl":"/m/hq/s/SAGE","defaultTab":"news","newsList":[{"id":"2450372033","title":"美国研究综述：波士顿啤酒公司、Inter Parfums、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2450372033","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450372033?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:46","pubTimestamp":1720770376,"startTime":"0","endTime":"0","summary":"    路透7月12日 - 华尔街证券分析师周五修订了对波士顿啤酒公司、Inter Parfums 和 Netflix 等几家美国上市公司的评级和目标价。亮点             * 波士顿啤酒公司  ：Piper Sandler 将该公司的目标价从 350 美元下调至 344 美元              * Inter Parfums Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入              * Netflix Inc   ：摩根大通将目标价从650美元上调至750美元              * Smurfit Westrock   ：摩根大通将该股列入分析师关注名单              * Vita Coco Company Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEI","SG9999004303.SGD","BK4146","BK4558","LU1861217088.USD","BSVN","LU1861220207.SGD","CPT","NKE","LU0234572021.USD","PTLO","BK4566","LU0786609619.USD","KALV","YMAB","IPAR","BK4201","BK4108","CPAY","OXY","BK4550","PNTG","SCHW","COCO","SW","EL","SAGE","BK4127","IE00B19Z8W00.USD","LU2360107671.USD","WPC","SAM","WEX","BK4548","PEP","SG9999001077.SGD","LU1046421795.USD","CAG","LU1153585028.USD","BK4009","WES","LU1303367103.USD","BK4177","LU2098885051.SGD","LU0266013472.USD","ZLAB","BK4209","IPG","NFLX","IDYA"],"gpt_icon":0},{"id":"2450385481","title":"美国研究综述-Nvidia、高通、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2450385481","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450385481?lang=zh_cn&edition=full","pubTime":"2024-07-10 15:41","pubTimestamp":1720597288,"startTime":"0","endTime":"0","summary":"    路透7月10日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括Nvidia、高通和特斯拉。* Nvidia Corp   ：KeyBanc将目标价上调至180美元 * 高通公司   ：KeyBanc将目标价上调至225美元  * 特斯拉  ：汇丰银行将目标价从120美元上调至130美元  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNLI","AMD","QCOM","GL","BK4559","SAIC","RNG","TWLO","SG9999014575.USD","KO","JXN","BK4177","CACI","FIVN","MPWR","MU","AFL","LZ","PRU","LGIH","RCUS","KDP","AMP","PFG","LDOS","ON","IE0004445015.USD","LU1169590202.USD","CRUS","SAGE","SG9999015986.USD","TSLL","TSLA","BAH","LU2237443382.USD","MOH","RGA","NICE","CNO","CNC","PRI","LU2237443549.SGD","NVDA","ENLC","BK4550","EQH","MRVL","DVN","BHF","NBIX"],"gpt_icon":1},{"id":"2446823273","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.10%报10.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446823273","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446823273?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:39","pubTimestamp":1719329989,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日23时39分，Sage Therapeutics, Inc.股票出现波动，股价大幅下挫5.10%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为318.29%、192.72%、167.69%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.、Effector Therapeutics, Inc.，振幅分别为67.71%、47.00%、34.28%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625233949941f0f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625233949941f0f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2444597263","title":"美国研究综述-花旗集团、耐克、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2444597263","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444597263?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:03","pubTimestamp":1718866998,"startTime":"0","endTime":"0","summary":"    路透6月20日 - 华尔街证券分析师周四调整了对花旗集团、耐克和特斯拉等多家美国上市公司的评级和目标价。* 花旗集团  ：KBW 将目标价从 66 美元上调至 69 美元             * Lennar Corp   ：Evercore ISI 将目标价从 238 美元下调至 237 美元             * 耐克公司  ：巴克莱将目标价从114美元下调至109美元             * 特斯拉  ：加拿大皇家银行将目标价从293美元下调至227美元 以下是路透周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU2023250504.SGD","KBH","LU1974910355.USD","LU0056508442.USD","ENPH","C","LU1861558580.USD","LU2756315318.SGD","INSM","LU1064131342.USD","LU2756315664.SGD","LU2087621335.USD","BK4147","BK4566","NEE","IE00BMG7P926.USD","LU1720051017.SGD","BFH","LU2098885051.SGD","LU2063271972.USD","LU0943347566.SGD","BK4207","ZIP","LU0052756011.USD","SAGE","IE00BWXC8680.SGD","BK4144","TSLL","TSLA","LU2637428348.USD","IE00BJTD4V19.USD","LU0198837287.USD","NKE","BK4527","BK4146","LU2326559502.SGD","LU1917777945.USD","IE00BD4GTV84.USD","BK4551","BK4099","BK4590","BK4592","LEN","BK4550","LU1303367103.USD","STZ","BK4561","ET","LU1668664300.SGD"],"gpt_icon":0},{"id":"2444263518","title":"美国研究综述-花旗集团、耐克、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2444263518","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444263518?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:03","pubTimestamp":1718866998,"startTime":"0","endTime":"0","summary":"    路透6月20日 - 华尔街证券分析师周四调整了对花旗集团、耐克和特斯拉等多家美国上市公司的评级和目标价。* 花旗集团  ：KBW 将目标价从 66 美元上调至 69 美元             * Lennar Corp   ：Evercore ISI 将目标价从 238 美元下调至 237 美元             * 耐克公司  ：巴克莱将目标价从114美元下调至109美元             * 特斯拉  ：加拿大皇家银行将目标价从293美元下调至227美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2756315664.SGD","LU0056508442.USD","KBH","BK4144","LU0198837287.USD","IE00BMG7P926.USD","LU1917777945.USD","ET","LU2087621335.USD","STZ","BK4146","NEE","LU2326559502.SGD","LU2637428348.USD","LU0052756011.USD","BK4590","BFH","BK4207","ENPH","IE00BJTD4V19.USD","LU2098885051.SGD","C","LU2063271972.USD","BK4504","BK4551","IE00BWXC8680.SGD","ZIP","LU1668664300.SGD","BK4566","BK4527","NKE","BK4592","BK4550","BK4099","LU0943347566.SGD","LU1303367103.USD","TSLA","TSLL","LU1064131342.USD","SAGE","LU2756315318.SGD","LU1974910355.USD","LU2023250504.SGD","INSM","LU1861558580.USD","BK4561","IE00BD4GTV84.USD","LU1720051017.SGD","LEN","BK4147"],"gpt_icon":0},{"id":"2443798106","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443798106","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443798106?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:37","pubTimestamp":1718375834,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时37分，Sage Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。消息层面，截至22时37分，《花旗维持Sage Therapeutics卖出评级，维持目标价8美元》资讯为影响Sage Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061422371496814550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061422371496814550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2443682775","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报11.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443682775","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443682775?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:31","pubTimestamp":1718289088,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时31分，Sage Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。消息层面，截至22时31分，《花旗维持Sage Therapeutics卖出评级，维持目标价8美元》资讯为影响Sage Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061322312896814079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061322312896814079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2442364780","title":"BUZZ-中期研究发现亨廷顿氏症药物安全，赛捷公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2442364780","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442364780?lang=zh_cn&edition=full","pubTime":"2024-06-11 19:31","pubTimestamp":1718105472,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    6月11日 - ** Sage Therapeutics   股价盘前上涨1.8%至11.10美元** 药物开发商称其药物dalzanemdor在一项名为亨廷顿氏病的罕见遗传性神经疾病患者的中期研究中被发现是安全的 (link)。** SAGE公司称，对亨廷顿病患者的研究并不是为了显示药物dalzanemdor与安慰剂之间存在统计学意义上的显著差异。** 截至上次收盘，该股今年累计下跌49.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SAGE","BUZZ"],"gpt_icon":0},{"id":"2442621364","title":"更新版 1-Sage Therapeutics 称中期研究发现罕见病药物是安全的","url":"https://stock-news.laohu8.com/highlight/detail?id=2442621364","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442621364?lang=zh_cn&edition=full","pubTime":"2024-06-11 19:24","pubTimestamp":1718105048,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第2段增加了研究细节，第3段增加了股票信息，第4段增加了背景信息)    路透6月11日 - Sage Therapeutics   周二称，在一项中期研究中，该公司的实验性药物被发现是安全的，并对一种罕见的遗传性神经疾病--亨廷顿氏症患者有一定疗效。但该公司表示，对亨廷顿病患者的研究并不是为了显示药物 dalzanemdor 与安慰剂之间的统计学差异。该公司股价最初飙升了 80%，但在震荡的盘前交易中抹去了这些涨幅，下跌了 1.6%。     这一消息是继该药物在帕金森病患者中进行中期试验失败后，  April (link)  。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2442366590","title":"Sage Therapeutics公司的罕见病药物在中期研究中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2442366590","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442366590?lang=zh_cn&edition=full","pubTime":"2024-06-11 18:38","pubTimestamp":1718102336,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月11日 - Sage Therapeutics公司  周二表示，其实验性药物在一种被称为亨廷顿氏症的罕见疾病患者的中期研究中达到了主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2439520128","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439520128","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439520128?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:35","pubTimestamp":1716989702,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时35分，Sage Therapeutics, Inc.股票出现波动，股价快速下挫5.28%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。该信息摘要如下：Sage Therapeutics Inc：贝尔德以中性评级和15美元的目标价启动保险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405292135029effe2b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405292135029effe2b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2439590147","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590147","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590147?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKNA","LU0006061336.USD","LYV","TKO","BAH","BK4528","PDFS","LU0310799852.SGD","ADI","BK4588","STZ","AKTS","PLMR","MNRO","IE00B7SZL793.SGD","CAH","AGIO","MCK","CASY","BK4139","BK4529","ADSK","LU0323240290.USD","LU1244550221.USD","MYRG","AAL","RLJ","HRT","TAP","CRVO","MSTR","NAPA","IBTX","INSM","TGI","BK4585","UAL","SAGE","BK4130","DOMO","RSI","LU1978683503.SGD","CAVA","IE00B19Z4B17.USD","MNMD","BK4214","BK4561","CTRE","COR","LU1642822529.SGD"],"gpt_icon":0},{"id":"2439590142","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590142","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590142?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADSK","BK4561","MNMD","RSI","PDFS","CAH","LU1244550221.USD","INSM","LU0310799852.SGD","AKTS","BK4585","BK4214","IBTX","MYRG","NAPA","BK4529","UAL","CASY","CTRE","LU1642822529.SGD","BAH","BK4588","IKNA","DOMO","TAP","LYV","RLJ","TGI","MNRO","AGIO","TKO","MSTR","COR","STZ","BK4528","MCK","ADI","SAGE","IE00B7SZL793.SGD","LU1978683503.SGD","HRT","PLMR","BK4130","LU0323240290.USD","CAVA","LU0006061336.USD","CRVO","AAL","IE00B19Z4B17.USD","BK4139"],"gpt_icon":0},{"id":"2435499519","title":"Sage Therapeutics, Inc.盘中异动 早盘急速拉升6.37%报12.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435499519","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435499519?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:33","pubTimestamp":1715693608,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时33分，Sage Therapeutics, Inc.股票出现异动，股价快速拉升6.37%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Nutriband Inc C/Wts 、Generation Bio Co.、Taysha Gene Therapies, Inc.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为37.56%、8.15%、7.04%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Absci Corporation、Fennec Pharmaceuticals Inc.，振幅分别为21.54%、13.83%、13.77%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514213328861ed179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514213328861ed179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2434600774","title":"Sage Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%报12.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434600774","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434600774?lang=zh_cn&edition=full","pubTime":"2024-05-09 01:43","pubTimestamp":1715190199,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日01时43分，Sage Therapeutics, Inc.股票出现波动，股价快速跳水5.01%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Brainstorm Cell Therapeutics Inc.涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为247.45%、110.26%、38.71%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Geovax Labs Inc C/Wts 29/09/2025、Cel-Sci Corporation，振幅分别为80.33%、60.74%、51.50%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050901431979268e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050901431979268e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2432708459","title":"Sage Therapeutics, Inc.盘中异动 股价大涨5.46%报13.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432708459","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432708459?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743166,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Sage Therapeutics, Inc.股票出现异动，股价急速上涨5.46%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为62.38%、21.87%、10.76%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032132467a57fb2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032132467a57fb2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2430788828","title":"高盛：维持Sage Therapeutics(SAGE.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430788828","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430788828?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:16","pubTimestamp":1714148170,"startTime":"0","endTime":"0","summary":"高盛：维持Sage Therapeutics(SAGE.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700161587b46444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700161587b46444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE"],"gpt_icon":0},{"id":"2430017287","title":"SAGE Therapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430017287","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430017287?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:56","pubTimestamp":1714057008,"startTime":"0","endTime":"0","summary":"   * SAGE Therapeutics Inc   报告了截至3月底的季度调整后每股亏损1.80美元，高于去年同期的每股亏损2.46美元。18位分析师对该季度的平均预期是每股亏损1.65美元。华尔街预期为每股亏损 2.16 美元至 1.26 美元。* SAGE Therapeutics 公司公布的本季度每股收益为亏损 1.80 美元。* SAGE Therapeutics Inc 本季度股价下跌了 25.3%，今年迄今为止下跌了 35.4%。4月25日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 12.8%。华尔街对 SAGE Therapeutics Inc 的 12 个月目标价中位数为 22.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2430103280","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.29%报14.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430103280","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430103280?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:26","pubTimestamp":1714055216,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时26分，Sage Therapeutics, Inc.股票出现波动，股价急速拉升5.29%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.75%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Processa Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1530.41%、207.34%、11.91%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Processa Pharmaceuticals, Inc.，振幅分别为54.48%、35.69%、32.10%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522265687e83c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522265687e83c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2430021324","title":"疫苗龙头，没了2800亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2430021324","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430021324?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:25","pubTimestamp":1714047925,"startTime":"0","endTime":"0","summary":"高光不再","market":"hk","thumbnail":"https://img3.gelonghui.com/d4adc-abc3c929-b511-4371-8478-b21853917ecb.png?guru_height=546&guru_width=707","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d4adc-abc3c929-b511-4371-8478-b21853917ecb.png?guru_height=546&guru_width=707"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/723988","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IE0002141913.USD","SG9999001440.SGD","LU1917777945.USD","BK0239","BK4550","LU1974910355.USD","BK0196","LU0070302665.USD","SG9999002224.SGD","SG9999014542.SGD","BK0046","LU2461242641.AUD","BK1200","LU0238689110.USD","09633","BK4007","BK4585","LU2023250504.SGD","LU1328615791.USD","SG9999014559.SGD","MRK","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU2148510915.USD","BK4139","LU0266013472.USD","BK4588","LU0234572021.USD","LU1430594728.SGD","LU1981816686.USD","IE00BSNM7G36.USD","LU1291159041.SGD","LU0965509010.AUD","LU0985320562.USD","LU0320765489.SGD","BK4516","LU0965509101.SGD","SAGE","IE00B2B36J28.USD","LU0861579265.USD","BK4559","IE0009355771.USD","LU1064131003.USD","BK0188","IE00BLSP4452.SGD","SG9999014575.USD","SG9999014567.USD","LU2106854487.HKD","SG9999002232.USD","300122"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagerx.com","stockEarnings":[{"period":"1week","weight":0.0451},{"period":"1month","weight":0.1433},{"period":"3month","weight":-0.078},{"period":"6month","weight":-0.5275},{"period":"1year","weight":-0.7301},{"period":"ytd","weight":-0.4329}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司，其使命是开拓解决方案，提供改变生命的大脑健康药物，让每个人都能茁壮成长。除了产后抑郁症商业产品外，该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司，该公司专注于大脑健康，目前他们的目标是两个关键的中枢神经系统受体系统，GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质，通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038293},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021443},{"month":3,"riseRate":0.4,"avgChangeRate":-0.042022},{"month":4,"riseRate":0.6,"avgChangeRate":0.045083},{"month":5,"riseRate":0.4,"avgChangeRate":-0.009805},{"month":6,"riseRate":0.5,"avgChangeRate":0.012627},{"month":7,"riseRate":0.5,"avgChangeRate":0.002472},{"month":8,"riseRate":0.7,"avgChangeRate":-0.023774},{"month":9,"riseRate":0.5,"avgChangeRate":-0.026052},{"month":10,"riseRate":0.4,"avgChangeRate":0.025122},{"month":11,"riseRate":0.7,"avgChangeRate":0.072175},{"month":12,"riseRate":0.6,"avgChangeRate":0.05379}],"exchange":"NASDAQ","name":"Sage Therapeutics","nameEN":"Sage Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sage Therapeutics,SAGE,Sage Therapeutics股票,Sage Therapeutics股票老虎,Sage Therapeutics股票老虎国际,Sage Therapeutics行情,Sage Therapeutics股票行情,Sage Therapeutics股价,Sage Therapeutics股市,Sage Therapeutics股票价格,Sage Therapeutics股票交易,Sage Therapeutics股票购买,Sage Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况